In summary, there is evidence that the cGAS–STING pathway may significantly contribute to the development of diabetes-related cardiac complications, and accurate modification of the cGAS–STING pathway of the heart may offer an essential contribution to the therapeutic and prognostic aspects of diabetic cardiomyopathy. Here, STING1 is linked to diabetic cardiomyopathy.